Sep 2026
IGF2BP3 enhances paclitaxel resistance in bladder urothelial carcinoma by recognizing m6A-modified CENPA mRNA
Targeting the IGF2BP3-CENPA axis may provide a novel therapeutic strategy to overcome chemoresistance in BUC.
Han-Jie Yi, Yong-Qing Han, Xia Wang et al.
· Medical Oncology · 0 citations